Primm is an international leading company engaged in the manufacturing, marketing and sale of Biotech Services and Products. The company was founded in 1990 and since then it has operated on the market of Custom Services for the scientific community addressing the growing needs of modern biomedical research for external services related to the manufacturing of specialized reagents or to the generation of analytical data based on the use of sophisticated instrumentation.

Primm today is one of the highly recognized companies able to provide advanced custom services like Antibodies, Peptides, DNA synthesis, DNA sequencing, Protein Analysis and a variety of pharmacological services based on the use of a modern state-of-the-art animal facility recently certified under the international GLP standards. During the past almost 20 years, the company has gained an international reputation as demonstrated by the prestigious customers in the US and in Europe presently using Primm services.

Locations
At present, Primm has laboratories, manufacturing facilities, and commercial offices in Italy, Switzerland and USA. Since 1995, its main Italian facility is located at the San Raffaele Biomedical Science Park, Milan, providing several core services to the local scientific community and where scientific interactions are being developed on a routine basis. In 1998, the company expanded its activities through the acquisition of both laboratories and a top-class animal facility located in the area of Treviso (Italy). This site is used for the production of polyclonal and monoclonal antibodies and to develop and perform various services, such as animal breeding and maintenance and pre-clinical studies.